IRF1 and melanoma: As shown in Figure D–H, R.E treatment enhanced pathwaysassociated with immune activation, including upregulation of ISGssuch as IRF1, MX1, and CXCL1, as well as pro-inflammatory cytokinesincluding TNF and IL6 in melanoma cells.